| The diarylquinoline TMC207 for multidrug-resistant tuberculosis AH Diacon, A Pym, M Grobusch, R Patientia, R Rustomjee, L Page-Shipp, ... New England Journal of Medicine 360 (23), 2397-2405, 2009 | 1066 | 2009 |
| Multidrug-resistant tuberculosis and culture conversion with bedaquiline AH Diacon, A Pym, MP Grobusch, JM de Los Rios, E Gotuzzo, I Vasilyeva, ... New England Journal of Medicine 371 (8), 723-732, 2014 | 864 | 2014 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 748 | 2021 |
| Phase 1 trials of rVSV Ebola vaccine in Africa and Europe ST Agnandji, A Huttner, ME Zinser, P Njuguna, C Dahlke, JF Fernandes, ... New England Journal of Medicine 374 (17), 1647-1660, 2016 | 506 | 2016 |
| Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug … AH Diacon, PR Donald, A Pym, M Grobusch, RF Patientia, R Mahanyele, ... Antimicrobial agents and chemotherapy 56 (6), 3271-3276, 2012 | 488 | 2012 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 469 | 2021 |
| Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study MS Arcilla, JM van Hattem, MR Haverkate, MCJ Bootsma, ... The Lancet infectious diseases 17 (1), 78-85, 2017 | 468 | 2017 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 348 | 2021 |
| Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study K Dheda, K Shean, A Zumla, M Badri, EM Streicher, L Page-Shipp, ... The Lancet 375 (9728), 1798-1807, 2010 | 322 | 2010 |
| Travel-associated infection presenting in Europe (2008–12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation P Schlagenhauf, L Weld, A Goorhuis, P Gautret, R Weber, ... The Lancet Infectious Diseases 15 (1), 55-64, 2015 | 302 | 2015 |
| Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled … JJ Aponte, D Schellenberg, A Egan, A Breckenridge, I Carneiro, ... The Lancet 374 (9700), 1533-1542, 2009 | 298 | 2009 |
| High recombination rate in natural populations of Plasmodium falciparum DJ Conway, C Roper, AMJ Oduola, DE Arnot, PG Kremsner, ... Proceedings of the National Academy of Sciences 96 (8), 4506-4511, 1999 | 298 | 1999 |
| Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases T Jelinek, C Schulte, R Behrens, MP Grobusch, JP Coulaud, Z Bisoffi, ... Clinical Infectious Diseases 34 (5), 572-576, 2002 | 294 | 2002 |
| Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities R McNerney, M Maeurer, I Abubakar, B Marais, TD Mchugh, N Ford, ... Journal of Infectious Diseases 205 (suppl_2), S147-S158, 2012 | 275 | 2012 |
| How useful is PCR in the diagnosis of malaria? T Hänscheid, MP Grobusch Trends in parasitology 18 (9), 395-398, 2002 | 262 | 2002 |
| Global phylogenetic analysis of Escherichia coli and plasmids carrying the mcr-1 gene indicates bacterial diversity but plasmid restriction S Matamoros, JM Van Hattem, MS Arcilla, N Willemse, DC Melles, ... Scientific reports 7 (1), 15364, 2017 | 253 | 2017 |
| Biological warfare, bioterrorism, and biocrime HJ Jansen, FJ Breeveld, C Stijnis, MP Grobusch Clinical Microbiology and Infection 20 (6), 488-496, 2014 | 236 | 2014 |
| Assessing the consequences of stigma for tuberculosis patients in urban Zambia AL Cremers, MM de Laat, N Kapata, R Gerrets, K Klipstein-Grobusch, ... PloS one 10 (3), e0119861, 2015 | 224 | 2015 |
| Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label … RW van Der Pluijm, R Tripura, RM Hoglund, AP Phyo, D Lek, A Ul Islam, ... The Lancet 395 (10233), 1345-1360, 2020 | 220 | 2020 |
| Drug-resistant tuberculosis—current dilemmas, unanswered questions, challenges, and priority needs A Zumla, I Abubakar, M Raviglione, M Hoelscher, L Ditiu, TD Mchugh, ... Journal of Infectious Diseases 205 (suppl_2), S228-S240, 2012 | 217 | 2012 |
